Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Iselin, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Outlook Therapeutics, Inc. has filed 815 SEC EDGAR filings since 10 Aug 2015

SEC filing history

Showing 626-650 of 815 matching filings.

Per page
25
Current page
26
EFFECT File 333-216080

EFFECT filing

Filing date
30 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-216080

POS AM

Filing date
27 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
27 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-223063

EFFECT filing

Filing date
28 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-216610

EFFECT filing

Filing date
23 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-212351

EFFECT filing

Filing date
23 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223064

FORM S-8

Filing date
15 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-223063

S-3

Filing date
15 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-212351

POS AM

Filing date
15 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-216610

POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1

Filing date
15 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89495

SC 13G/A

Filing date
15 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
14 Feb 2018
Reporting date
13 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89495

ONCOBIOLOGICS, INC.

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
09 Feb 2018
Reporting date
09 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
07 Feb 2018
Reporting date
01 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-37759

FORM 10-K/A

Filing date
29 Jan 2018
Reporting date
30 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89495

SABBY 13G-A ONS 1.05.18

Filing date
05 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37759

FORM 8-K

Filing date
04 Jan 2018
Reporting date
28 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-222387

FORM S-3

Filing date
02 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .